Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2021-001453-31Phase 2Completed
Phase 2, randomised trial in disorder of consciousness (DOC) comparing Methylphenidate sequence, Apomorphine sequence and Placebo sequence (3 arms). Primary endpoint: Primary endpoint 1. Started Mar 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2021-001453-31.